NCT03514407 2025-10-21A Study of INCB059872 in Relapsed or Refractory Ewing SarcomaIncyte CorporationPhase 1 Terminated25 enrolled
NCT05605522 2025-08-24A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours3B Pharmaceuticals GmbHPhase 1 Terminated19 enrolled
NCT02657005 2025-02-12TK216 in Patients With Relapsed or Refractory Ewing SarcomaOncternal Therapeutics, IncPhase 1/2 Terminated85 enrolled 18 charts
NCT03604783 2024-09-19Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid TumorsSumitomo Pharma America, Inc.Phase 1 Terminated74 enrolled
NCT03458728 2023-12-04Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric PatientsBayerPhase 1/2 Terminated31 enrolled 17 charts
NCT00617890 2018-08-23A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)Merck Sharp & Dohme LLCPhase 2 Terminated219 enrolled 13 charts